News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
NeonMind Submits Applications to Health Canada for Product Formulas to Support Cognitive and Immune Function and to Fight Stress
NeonMind Biosciences Inc.
JJ Wilson | Chairman of the Board, Optimi Health
Optimi Health
Core One Labs Announces Adding Video Conference Capabilities to Teleconference Call Scheduled for February 10, 2021 1:30 p.m. PST/4:30 p.m. EST
Core One Labs Inc.
Mydecine Innovations Group Files Final Prospectus in Connection with Bought Deal Offering of Units
Mydecine Innovations Group
Revive Therapeutics Receives Receipt for Final Short-Form Prospectus for Previously Announced $20 Million Bought Deal Public Offering
Revive Therapeutics
Nova Mentis Psilocybin Approved for Shipment to Italy
Nova Mentis Life Science
Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and Cultivation Facility in Jamaica
Field Trip Health
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists
Compass Pathways
Tryp Therapeutics Plans Phase 2a Eating Disorder Clinical Trial with Dr. Jennifer Miller
Tryp Therapeutics
Revive Therapeutics Files Business Acquisition Report
Revive Therapeutics
PharmaDrug Appoints World-Renowned DMT Expert Dr. Steven A. Barker to Its Scientific Advisory Board for Psychedelic Pharmaceuticals
Pharmadrug Inc.
Core One Labs Engages Donohoe Advisory for Nasdaq Listing and Schedules Special Investor Call with Dr. Robert E.W. Hancock to Demonstrate Recent Research Outcome
Core One Labs Inc.
PharmaDrug Grants Stock Options
Pharmadrug Inc.
Mindset Files Multiple Final Patent Applications on Its Novel Psilocybin-Inspired Compounds
Mindset Pharma
Mydecine Innovations Group Files Amended and Restated Financial Statements
Mydecine Innovations Group
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.